Testosterone replacement therapy and prostate cancer: the downfall of a paradigm?
作者： Octavio A. Castillo , Ivar Vidal-Mora , Gastón López-Fontana
DOI: 10.5867/MEDWAVE.2015.03.6115
关键词:
摘要: For six decades, it has been a part of the conventional medical wisdom that higher levels testosterone increase risk prostate cancer. This belief is mostly derived from well-documented regression cancer after surgical or pharmacological castration. However, there an absence scientific data supporting concept are associated with increased Moreover, men hypogonadism have substantial rates in prostatic biopsies, suggesting low no protective effect against development rate elderly patients when hormonal low. These results argue replacement therapy.
unab.cl
sci-hub.st 参考文章(41)
Juan Morote, Cristobal Ramirez, Esther Gómez, Jacques Planas, Carles X Raventós, Inés M De Torres, Roberto Catalán, None, The relationship between total and free serum testosterone and the risk of prostate cancer and tumour aggressiveness. BJUI. ,vol. 104, pp. 486- 489 ,(2009) , 10.1111/J.1464-410X.2009.08378.X
Abraham Morgentaler, Carl O Bruning, William C DeWolf, Occult Prostate Cancer in Men With Low Serum Testosterone Levels JAMA: The Journal of the American Medical Association. ,vol. 276, pp. 1904- 1906 ,(1996) , 10.1001/JAMA.1996.03540230054035
Mustafa Sofikerim, Sadettin Eskicorapcı, Özgür Oruç, Haluk Özen, Hormonal Predictors of Prostate Cancer Urologia Internationalis. ,vol. 79, pp. 13- 18 ,(2007) , 10.1159/000102906
MICHAEL A. HOFFMAN, WILLIAM C. DeWOLF, ABRAHAM MORGENTALER, IS LOW SERUM FREE TESTOSTERONE A MARKER FOR HIGH GRADE PROSTATE CANCER The Journal of Urology. ,vol. 163, pp. 824- 827 ,(2000) , 10.1016/S0022-5347(05)67812-3
Culley Carson, Roger Rittmaster, The role of dihydrotestosterone in benign prostatic hyperplasia Urology. ,vol. 61, pp. 2- 7 ,(2003) , 10.1016/S0090-4295(03)00045-1
H. Ballentine Carter, Jay D. Pearson, E. Jeffrey Metter, Daniel W. Chan, Reubin Andres, James L. Fozard, William Rosner, Patrick C. Walsh, Longitudinal evaluation of serum androgen levels in men with and without prostate cancer. The Prostate. ,vol. 27, pp. 25- 31 ,(1995) , 10.1002/PROS.2990270106
A. Edward Friedman, Re: Testosterone Therapy in Men With Untreated Prostate Cancer Journal of Urology. ,vol. 186, pp. 1559- 1560 ,(2011) , 10.1016/J.JURO.2011.05.064
Y Cui, H Zong, H Yan, Y Zhang, The effect of testosterone replacement therapy on prostate cancer: a systematic review and meta-analysis Prostate Cancer and Prostatic Diseases. ,vol. 17, pp. 132- 143 ,(2014) , 10.1038/PCAN.2013.60
Ahmed I. El‐Sakka, Howayda M. Hassoba, Adel M. Elbakry, Hassan A. Hassan, Prostatic specific antigen in patients with hypogonadism: effect of testosterone replacement. The Journal of Sexual Medicine. ,vol. 2, pp. 235- 240 ,(2005) , 10.1111/J.1743-6109.2005.20233.X
Abraham Morgentaler, Abdulmaged M. Traish, Shifting the Paradigm of Testosterone and Prostate Cancer: The Saturation Model and the Limits of Androgen-Dependent Growth European Urology. ,vol. 55, pp. 310- 321 ,(2009) , 10.1016/J.EURURO.2008.09.024